Development of thieno- and benzopyrimidinone inhibitors of the Hedgehog signaling pathway reveals PDE4-dependent and PDE4-independent mechanisms of action.

Hempel JE, Cadar AG, Hong CC
Bioorg Med Chem Lett. 2016 26 (8): 1947-53

PMID: 26976215 · PMCID: PMC5147493 · DOI:10.1016/j.bmcl.2016.03.013

From a high content in vivo screen for modulators of developmental patterning in embryonic zebrafish, we previously identified eggmanone (EGM1, 3) as a Hedgehog (Hh) signaling inhibitor functioning downstream of Smoothened. Phenotypic optimization studies for in vitro probe development utilizing a Gli transcription-linked stable luciferase reporter cell line identified EGM1 analogs with improved potency and aqueous solubility. Mechanistic profiling of optimized analogs indicated two distinct scaffold clusters: PDE4 inhibitors able to inhibit downstream of Sufu, and PDE4-independent Hh inhibitors functioning between Smo and Sufu. Each class represents valuable in vitro probes for elucidating the complex mechanisms of Hh regulation.

Published by Elsevier Ltd.

MeSH Terms (12)

Cyclic Nucleotide Phosphodiesterases, Type 4 Dose-Response Relationship, Drug Hedgehog Proteins HEK293 Cells Humans Molecular Structure Phosphodiesterase 4 Inhibitors Pyrimidinones Repressor Proteins Signal Transduction Smoothened Receptor Structure-Activity Relationship

Connections (2)

This publication is referenced by other Labnodes entities: